Page 2 - Les meilleurs doctors en en Israël - TOP-28 des médecins

Reconnu par Forbes comme l'un des meilleurs médecins en 2018 – Le Dr Stepensky a réalisé plus de 3 500 greffes de moelle osseuse au centre médical Hadassah.

• Plus de 20 ans de spécialisation dans les greffes de moelle osseuse pédiatriques
• Axé sur les maladies rares du cancer du sang chez les enfants
• Connu des patients comme « celui qui transplante la vie »
• Dirige une unité d'hématologie pédiatrique dédiée

Le Dr Irina Zaidman est spécialisée en transplantation de moelle osseuse pédiatrique, formée dans les meilleures institutions mondiales, notamment l'Hospital for Sick Children de Toronto.

• Membre du conseil d'administration de la Société israélienne d'hémato-oncologie pédiatrique
• Active dans l'enseignement et la recherche sur les transplantations pédiatriques
• Membre des sociétés européenne et américaine de BMT
• A publié de nombreux articles sur les transplantations de moelle osseuse pédiatriques

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Le Dr Ofer Spielberg est un oncohématologue au centre médical Assuta, spécialisé dans les cancers du sang tels que le lymphome et la leucémie.

• Se concentre exclusivement sur les hémopathies malignes et les troubles sanguins complexes
• Expert en greffe de moelle osseuse et protocoles de traitement modernes
• Fournit des soins personnalisés dans le premier hôpital privé d'Israël